European Summit on Pharmacology

Biography

Dr R. Andrew Paskauskas is a multidisciplinary researcher with a strong background in bioinformatics, medical sciences, and biotechnology innovation. He holds an MSc in Bioinformatics from the University of Oxford and a PhD in Science and Technology from the University of Toronto, where he specialised in the history of medicine, neurosciences, and the early neurological work of Ernest Jones and Sigmund Freud. His research culminated in the publication of the Complete Correspondence between Sigmund Freud and Ernest Jones (1908–1939) by Harvard University Press, a seminal work in medical and psychoanalytic history.

Dr. Paskauskas was a Canada Research Fellow in the Faculty of Medicine at McGill University, where he continued his research into historical and neurological aspects of Freud’s and Jones’s work. His supervisor at McGill was among the laureates awarded the 1985 Nobel Peace Prize to the International Physicians for the Prevention of Nuclear War (IPPNW). He has published extensively on early neurological theories, making significant contributions to the understanding of Freud’s pioneering neurophysiological studies and their intersections with modern neurosciences.

Expanding his expertise into computational biology, Dr. Paskauskas pursued bioinformatics at Oxford, later serving as Chief Scientist under the leadership of Dr. William G. Tucker at Biomolecular Pharma, a Canadian university spin-off company focused on biopharmaceutical innovation in brain cancer research. His bioinformatics research included computational modelling of Synencephalin in the computational laboratory of Dr. David Baker, who was awarded the 2024 Nobel Prize in Chemistry for his groundbreaking work in computational protein design.

He has recently turned his attention to cybersecurity, 5G infrastructure security, and quantum computing as a disruptive technology. In addition to advancing research on cybersecurity and AI-driven medical diagnostics, he has explored the MS-measles virus hypothesis, examining potential links between measles virus infection and the pathogenesis of multiple sclerosis. His work has also extended to computational modelling of potential drug candidates for treating brain cancer, employing bioinformatics-driven artificial intelligence approaches to identify novel therapeutic pathways.

As principal Keynote Speaker and Chair of the Infectious Diseases Conference (Dubai, March 10-11, 2025), Dr. Paskauskas brought a wealth of experience at the intersection of computational biology, infectious disease research, and biomedical innovation. His work continues to shape strategies for understanding and mitigating the risks of neurotropic pathogens, brain cancer, and emerging infectious diseases, leveraging advanced knowledge graph technologies and AI to enhance diagnostic and therapeutic approaches.